MP61-16 PRE-CLINICAL AND CLINICAL TRANSLATION OF A TISSUE ENGINEERED NEO−URINARY CONDUIT USING ADIPOSE DERIVED SMOOTH MUSCLE CELLS FOR URINARY RECONSTRUCTION
Trinity Bivalacqua(University of Baltimore), Mark Schoenberg(Montefiore Medical Center), Deepak Jain, Cheryl Lee(Agency for Science, Technology and Research), Seth P. Lerner(Baylor College of Medicine), Timothy H. Bertram(University of Wisconsin–Madison), Elias Rivera, Norm D. Smith(Caris Life Sciences (United States)), Gary K. Steinberg(Palo Alto University)
Cited by 4
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427
Transfusion guidelines for neonates and older children
|British Journal of Haematology|2004|371